Piperacillin and Tazobactam, a combination penicillin antibiotic and beta-lactamase inhibitor, is indicated for the treatment of moderate to severe infections caused by susceptible isolates of certain bacteria. It works by inhibiting bacterial cell wall synthesis by binding to one or more of the penicillin-binding proteins (PBPs) which inhibit the final transpeptidation step of peptidoglycan synthesis in bacterial cell walls. Piperacillin exhibits time-dependent killing and tazobactam inhibits beta-lactamases.
Piperacillin and Tazobactam for Injection is available as a 3.375g strength in single-dose vials.
For more information call (800) 796-9526 or visit Mylan.com.